ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $12,834,000 | +56.5% | 3,130,192 | +36.3% | 5.32% | +41.4% |
Q4 2021 | $8,202,000 | +753.5% | 2,297,360 | +769.9% | 3.76% | +761.3% |
Q3 2021 | $961,000 | -70.5% | 264,100 | -78.1% | 0.44% | -87.1% |
Q3 2020 | $3,255,000 | +811.8% | 1,205,501 | +697.3% | 3.39% | +795.8% |
Q1 2020 | $357,000 | – | 151,189 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |